Torrent Pharma gears up to buyout Cipla promoters, approach PE funding
Torrent Pharma is working to secure the necessary funds to buyout the promoter family of Cipla, according to a report by the Economic Times (ET)....
Continue ReadingPharma Award Finalists for CPHI Barcelona Have Been Announced
CPHI Barcelona announced the finalists for the 2023 CPHI Pharma Awards. The awards ceremony will be held on Oct. 24, 2023, the opening day of...
Continue ReadingSun Pharma partners with USA’s Pharmazz to bring an innovative stroke drug to India
Global pharma giant Sun Pharmaceutical Industries Limited announced that it had entered into a licence agreement with American biopharmaceutical company Pharmazz Inc to commercialise an...
Continue ReadingLupin partners with Mark Cuban and COPD Foundation to expand access to COPD medication in the US
COPD affects over 15 million adults in the US and ranks as the fourth leading cause of death. It is a chronic respiratory condition that...
Continue ReadingBiocon Biologics completes integration of Viatris biosimilars business in North America
Biocon said its arm Biocon Biologics has completed the integration of the acquired biosimilars business from Viatris in North America with effect from September 1,...
Continue ReadingCipla teams up with Pocket Aces for slice-of-life films on dispelling asthma myths
Cipla Ltd.’s #BerokZindagi, partners with digital entertainment companies, Pocket Aces, to create multiple sketches for the platform’s leading short-form content channel – FilterCopy. By harnessing...
Continue ReadingZydus Lifesciences receives USFDA approval for Erythromycin
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP, available in strengths of 250...
Continue ReadingMystery respiratory virus hits Hyderabad, dodges tests & jolts doctors
At a time when neighbouring states like Maharashtra and Karnataka have sounded an alarm over the increasing number of swine flu cases, back home in...
Continue ReadingShilpa Pharma Lifesciences Unit II Raichur facility clears PMDA Japan GMP inspection
Shilpa Medicare Limited has announced that PMDA, Japan has successfully concluded GMP inspection without any critical/major observation at the company’s 100% subsidiary, Shilpa Pharma Lifesciences...
Continue Reading